Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events
Non-Viral Gene Delivery Technologies Market Size to Hit USD 9.57 Billion by 2033, Growing at a CAGR of 12.55% - SNS Insider [Yahoo! Finance]
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Piper Sandler from $70.00 to $100.00. They now have an "overweight" rating on the stock.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Royal Bank Of Canada from $52.00 to $80.00. They now have an "outperform" rating on the stock.